Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease

American Journal of Respiratory and Critical Care Medicine

Volumn 173, Issue 9, 2006, Pages 991-998

  Sethi, Sanjay ^a   Maloney, Jane ^b   Grove, Lori ^b   Wrona, Catherine ^b   Berenson, Charles S ^b  

^a VA WESTERN NEW YORK HEALTHCARE SYSTEM   (United States)

^b NONE

Author keywords

Bacterial colonization; Chronic obstructive pulmonary disease; Neutrophilic inflammation

Indexed keywords

CHEMOKINE; CYTOKINE; ENDOTOXIN; GELATINASE B; INTERLEUKIN 8; PROTEINASE; PROTEINASE INHIBITOR; TOBACCO SMOKE;

ADULT; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BRONCHOSCOPY; CELL COUNT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; HUMAN; LUNG INFECTION; LUNG LAVAGE; MALE; NEUTROPHIL; PATHOGENESIS; PNEUMONIA; PRIORITY JOURNAL; SMOKING;

AGE FACTORS; AGED; BRONCHI; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOSCOPY; CASE-CONTROL STUDIES; COLONY COUNT, MICROBIAL; CYTOKINES; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SMOKING;

EID: 33646244263     PISSN: 1073449X     EISSN: 1073449X     Source Type: Journal    
DOI: 10.1164/rccm.200509-1525OC     Document Type: Article

References (39)

1. Barnes PJ. Chronic obstructive pulmonary disease. N Engl J Med 2000;343:269-280.
2. Turato G, Di Stefano A, Maestrelli P, Mapp CE, Ruggieri MP, Roggeri A, Fabbri LM, Saetta M. Effect of smoking cessation on airway inflammation in chronic bronchitis. Am J Respir Crit Care Med 1995;152:1262-1267.
3. Wright JL, Lawson LM, Pare PD, Wiggs BR, Kennedy S, Hogg JC. Morphology of peripheral airways in current smokers and ex-smokers. Am Rev Respir Dis 1983;127:474-477.
4. Mullen JBM, Wright JL, Wiggs BR, Pare PD, Hogg JC. Structure of central airways in current smokers and ex-smokers with and without mucus hypersecretion: relationship to lung function. Thorax 1987;42:843-848.
5. Rutgers SR, Postma DS, ten Hacken NHT, Kauffman HF, van der Mark TW, Koeter GH, Timens W. Ongoing airway inflammation in patients with COPD who do not currently smoke. Thorax 2000;55:12-18.
6. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004;350:2645-2653.
7. Barnes PJ. Small airways in COPD. N Engl J Med 2004;350:2635-2637.
8. Anthonisen NR, Connett JE, Murray RP. Smoking and lung function of Lung Health Study participants after 11 years. Am J Respir Crit Care Med 2002;166:675-679.
9. Sethi S, Murphy TF. Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review. Clin Microbiol Rev 2001;14:336-363.
10. Vitalis TZ, Kern I, Croome A, Behzad H, Hayashi S, Hogg JC. The effect of latent adenovirus 5 infection on cigarette smoke-induced lung inflammation. Eur Respir J 1998;11:664-669.
11. Matsuse T, Hayashi S, Kuwano K, Keunecke H, Jefferies WA, Hogg JC. Latent adenoviral infection in the pathogenesis of chronic airways obstruction. Am Rev Respir Dis 1992;146:177-184.
12. von Hertzen L, Alakarppa H, Koskinen R, Liippo K, Surcel H-M, Leinonen M, Saikku P. Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease. Epidemiol Infect 1997;118:155-164.
13. Morris A, Sciurba FC, Lebedeva IP, Githaiga A, Elliott WM, Hogg JC, Huang L, Norris KA. Association of chronic obstructive pulmonary disease severity and pneumocystis colonization. Am J Respir Crit Care Med 2004;170:408-413.
14. Murphy TF, Brauer AL, Schiffmacher AT, Sethi S. Persistent Colonization by Haemophilus influenzae in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2004;170:266-272.
15. Banerjee D, Khair OA, Honeybourne D. Impact of sputum bacteria on airway inflammation and health status in clinical stable COPD. Eur Respir J 2004;23:685-691.
16. 1 decline in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003;167:1090-1095.
17. Hill AT, Campbell EJ, Hill SL, Bayley DL, Stockley RA. Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis. Am J Med 2000;109:288-295.
18. Patel IS, Seemungal TA, Wilks M, Lloyd-Owen SJ, Donaldson GC, Wedzicha JA. Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax 2002;57:759-764.
19. Bresser P, Out TA, van Alphen L, Jansen HM, Lutter R. Airway inflammation in nonobstructive and obstructive chronic bronchitis with chronic Haemophilus influenzae airway infection: comparison with noninfected patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000;162:947-952.
20. Soler N, Ewig S, Torres A, Filella X, Gonzalez J, Zaubet A. Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease. Eur Respir J 1999;14:1015-1022.
21. Thompson AB, Daughton D, Robbins RA, Ghafouri MA, Oehlerking M, Rennard SI. Intraluminal airway inflammation in chronic bronchitis: characterization and correlation with clinical parameters. Am Rev Respir Dis 1989;140:1527-1537.
22. Sun G, Stacey MA, Vittori E, Marini M, Bellini A, Kleimberg J, Mattoli S. Cellular and molecular characteristics of inflammation in chronic bronchitis. Eur J Clin Invest 1998;28:364-372.
23. Sethi S, Maloney J, Grove L, Smigiera J, Berenson C. Colonization of the lower respiratory tract and airway neutrophilia in ex-smokers with stable COPD. American Thoracic Society International Conference, Seattle, WA, May 2003.
24. Sethi S, Maloney J, Grove L, Wrona C, Berenson CS. Bacterial colonization of the lower respiratory tract is associated with airway inflammation in ex-smokers with stable COPD. American Thoracic Society International Conference, Orlando, FL, May 2004.
25. Sethi S, Wrona C, Maloney J, Berenson C. Bacterial colonization is associated with increased matrix metalloproteinase-9 (MMP-9) in bronchoalveolar lavage of ex-smokers with stable COPD. American Thoracic Society International Conference, San Diego, CA, May 2005.
26. Rosell A, Monso E, Soler N, Torres F, Angrill J, Riise G, Zalacain R, Morera J, Torres A. Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease. Arch Intern Med 2005;165:891-897.
27. Earley M Jr, ogt R, Shapiro H, Mandy FF, Keller K, Bellisario R, Pass K, Marti G, Stewart C, Hannon W. Report from a workshop on multianalyte microsphere assays. Cytometry 2002;50:239-242.
28. National Institutes of Health, National Heart, Lung, and Blood Institute, World Health Organization. Executive summary: global strategies for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Bethesda, MD: National Institutes of Health, National Heart, Lung, and Blood Institute, and World Health Organization; 2004.
29. Tanino M, Betsuyaku T, Takeyabu K, Tanino Y, Yamaguchi E, Miyamoto K, Nishimura M. Increased levels of interleukin-8 in BAL fluid from smokers susceptible to pulmonary emphysema. Thorax 2002;57:405-411.
30. O'Donnell RA, Peebles C, Ward JA, Daraker A, Angco G, Broberg P, Pierrou S, Lund J, Holgate ST, Davies DE, et al. Relationship between peripheral airway dysfunction, airway obstruction, and neutrophilic inflammation in COPD. Thorax 2004;59:837-842.
31. Fuke S, Betsuyaku T, Nasuhara Y, Morikawa T, Katoh H, Nishimura M. Chemokines in bronchiolar epithelium in the development of chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2004;31:405-412.
32. Sethi S, Evans N, Grant BJB, Murphy TF. Acquisition of a new bacterial strain and occurrence of exacerbations of chronic obstructive pulmonary disease. N Engl J Med 2002;347:465-471.
33. Sha Q, Truong-Tran AQ, Plitt JR, Beck LA, Schleimer RP. Activation of airway epithelial cells by Toll-like receptor agonists. Am J Respir Cell Mol Biol 2004;31:358-364.
34. Berenson CS, Murphy TF, Wrona CT, Sethi S. Outer membrane protein P6 of nontypeable Haemophilus influenzae is a potent and selective inducer of human macrophage proinflammatory cytokines. Infect Immun 2005;73:2728-2735.
35. Gibson RL, Burns JL, Ramsey BW. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 2003;168:918-951.
36. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984;1:1311-1315.
37. Saikku P, Leinonen M, Mattila K, Ekman MR, Nieminen MS, Makela PH, Huttunen JK, Valtonen V. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988;2:983-986.
38. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002;347:417-429.
39. Zalacain R, Sobradillo V, Amilibia J, Barron J, Achotegui V, Pijoan JI, Llorente JL. Predisposing factors to bacterial colonization in chronic obstructive pulmonary disease. Eur Respir J 1999;13:343-348.